COMPARISON TOOL
Compare peptides
Half-life, dosing, mechanism, status — side by side. Select up to four compounds, or start from a preset.
BPC-157Max 4 peptides
| Property | BPC-157 |
|---|---|
| Category | Healing |
| Type | Peptide |
| Mechanism | Gastric pentadecapeptide; angiogenic and growth-factor signalling (VEGFR2, NO) |
| Status | Compounded (Rx) |
| Dosing range | 200–500 mcg, 1–2× daily |
| Frequency | Once or twice daily |
| Half-life | Under 30 minutes (animal data) |
| Route | Subcutaneous (oral for gut) |
| Onset | 1–2 weeks |
| Studied for |
|
| Key risks |
|
| Storage | Refrigerated (2–8 °C); use within the pharmacy beyond-use date |
| Available at G1 | Vials: 5 mg, 10 mgPens: Wolverine, Wolverine-S, GLOW, KLOW, X-23Shop → |
| Tools | Dosage calculator → |
PROPERTY COMPARISON · RADAR
Profile shape
TYPICAL DOSE RANGES
Dose envelope
BPC-157200 mcg – 500 mcg
Typical per-dose range on a logarithmic scale. Your provider sets your dose.
For educational purposes only. Consult a licensed provider before starting any peptide protocol.